# Choice Hotels International Inc: overview

CHH · NYSE · CIK 1046311 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/chh.md) · [Financials](/companies/chh/financials.md) · [Filings](/companies/chh/filings.md) · [Insiders](/companies/chh/insiders.md)

Latest reported revenue: [$440.8m](/filings/0001046311-26-000025.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 5, 2026 (XBRL us-gaap:Revenues, accession 0001046311-26-000025).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [428](/filings/0001046311-24-000036.md) | [390 d](/filings/0001046311-26-000008.md) | [333](/filings/0001046311-26-000019.md) | [426](/filings/0001046311-26-000025.md) | [447](/filings/0001046311-25-000030.md) | [390 d](/filings/0001046311-26-000008.md) | [341](/filings/0001046311-26-000019.md) | [441](/filings/0001046311-26-000025.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [35.5%](/filings/0001046311-25-000030.md) | [30.6% d](/filings/0001046311-26-000008.md) | [24.0%](/filings/0001046311-26-000019.md) | [29.2%](/filings/0001046311-26-000025.md) | [31.8%](/filings/0001046311-25-000030.md) | [26.0% d](/filings/0001046311-26-000008.md) | [17.6%](/filings/0001046311-26-000019.md) | [23.6%](/filings/0001046311-26-000025.md) |
| Net margin | % | [24.7%](/filings/0001046311-25-000030.md) | [19.4% d](/filings/0001046311-26-000008.md) | [13.4%](/filings/0001046311-26-000025.md) | [19.2%](/filings/0001046311-26-000025.md) | [40.2%](/filings/0001046311-25-000030.md) | [16.3% d](/filings/0001046311-26-000008.md) | [6.0%](/filings/0001046311-26-000025.md) | [14.6%](/filings/0001046311-26-000025.md) |
| Diluted EPS | $ per share | [2.22](/filings/0001046311-25-000030.md) | not reported | [0.94](/filings/0001046311-26-000019.md) | [1.75](/filings/0001046311-26-000025.md) | [3.86](/filings/0001046311-25-000030.md) | not reported | [0.44](/filings/0001046311-26-000019.md) | [1.41](/filings/0001046311-26-000025.md) |
| Free cash flow | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,069](/filings/0001046311-24-000010.md) | [1,402](/filings/0001046311-24-000010.md) | [1,544](/filings/0001046311-24-000010.md) | [1,585](/filings/0001046311-26-000008.md) | [1,597](/filings/0001046311-26-000008.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [40.1%](/filings/0001046311-24-000010.md) | [34.1%](/filings/0001046311-25-000007.md) | [24.3%](/filings/0001046311-26-000008.md) | [29.3%](/filings/0001046311-26-000008.md) | [28.1%](/filings/0001046311-26-000008.md) |
| Net margin | % | [27.0%](/filings/0001046311-24-000010.md) | [23.7%](/filings/0001046311-25-000007.md) | [16.7%](/filings/0001046311-26-000008.md) | [18.9%](/filings/0001046311-26-000008.md) | [23.2%](/filings/0001046311-26-000008.md) |
| Diluted EPS | $ per share | [5.15](/filings/0001046311-24-000010.md) | [5.99](/filings/0001046311-25-000007.md) | [5.07](/filings/0001046311-26-000008.md) | [6.20](/filings/0001046311-26-000008.md) | [7.90](/filings/0001046311-26-000008.md) |
| Free cash flow | $m | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/chh/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BAMCO INC /NY/](/funds/1017918.md) | 2026-06-30 | $1.03bn | 9,328,354 |  | Added +1,637,860 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $318.8m | 2,891,235 |  | Reduced −344,597 |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $249.9m | 2,266,537 |  | Added +114,601 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $121.0m | 1,097,011 |  | Added +27,457 |
| [Balyasny Asset Management L.P.](/funds/1218710.md) | 2026-06-30 | $120.6m | 1,093,391 |  | Reduced −78,198 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $118.4m | 1,074,081 |  | Reduced −19,127 |
| [KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC](/funds/1021223.md) | 2026-06-30 | $101.1m | 917,152 |  | Reduced −2,304,589 |
| [Voss Capital, LP](/funds/1730145.md) | 2026-06-30 | $100.3m | 910,000 |  | Reduced −57,500 |
| [Boston Trust Walden Corp](/funds/1534866.md) | 2026-06-30 | $99.1m | 898,930 |  | Reduced −31,832 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $82.3m | 746,563 |  | Added +13,143 |

## Recent filings

[All 2,183 filings](/companies/chh/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-01 | 13:00 ET | [8-K](/filings/0001193125-26-409974.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-409974 |
| 2026-08-31 | 13:05 ET | [8-K](/filings/0001193125-26-375580.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-375580 |
| 2026-08-28 | 20:15 ET | [8-K](/filings/0001193125-26-374377.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-374377 |
| 2026-08-05 | 15:22 ET | [10-Q](/filings/0001046311-26-000025.md) | Quarterly report, period 2026-06-30 | 0001046311-26-000025 |
| 2026-08-05 | 12:35 ET | [8-K](/filings/0001046311-26-000023.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001046311-26-000023 |
| 2026-07-01 | 14:37 ET | [8-K](/filings/0001628280-26-046377.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-26-046377 |
| 2026-05-21 | 20:54 ET | [8-K](/filings/0001193125-26-234741.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-234741 |
| 2026-05-20 | 20:10 ET | [8-K](/filings/0001193125-26-232581.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-232581 |
| 2026-04-30 | 16:20 ET | [10-Q](/filings/0001046311-26-000019.md) | Quarterly report, period 2026-03-31 | 0001046311-26-000019 |
| 2026-04-30 | 12:33 ET | [8-K](/filings/0001046311-26-000017.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001046311-26-000017 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001046311-26-000008.md), filed Feb 19, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/8de274c2-7784-45d8-9050-76d2c39b4d6b)

## About the filer

- CIK: 1046311
- Tickers: CHH
- Exchange: NYSE
- SIC code: 7011 Hotels & Motels
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:31 ET. No prices; not investment advice.